Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake

Mundt, B.; Wirth, T.; Zender, L.; Waltemathe, M.; Trautwein, C.; Manns, M. P.; Kühnel, F.; Kubicka, S.
November 2005
Gut;Nov2005, Vol. 54 Issue 11, p1590
Academic Journal
Background and aims: Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces apoptosis in transformed cells and is considered as an agent for cancer therapy. As there is evidence that TRAIL is also essential for apoptosis in animal models of liver injury, we investigated the role of TRAIL in viral hepatitis and after alcohol consumption. Methods: Expression of TRAIL was determined by western blot analysis in the liver of patients with chronic hepatitis C virus (HCV) infection as well as in experimental acute adenoviral hepatitis and after alcohol intake in the liver of mice. To investigate the effect of FasL and TRAIL expression, we used low dose adenoviral gene transfer. Apoptosis and steatosis were assessed by TUNEL and fat red staining, and by caspase assays. Results: TRAIL was overexpressed in the liver of patients with HCV associated steatosis while acute adenoviral hepatitis resulted in upregulation of TRAIL-DR5. In contrast with FasL, TRAIL expression was harmless to healthy livers. However, in virally infected livers, TRAIL expression induced apoptosis and steatosis whereas expression of FasL only resulted in apoptosis of hepatocytes without steatosis. After alcohol intake, TRAIL expression led to hepatic steatosis, without apoptosis of hepatocytes, indicating that TRAIL mediated apoptosis and steatosis may be independently modulated after viral infection and alcohol intake. In viral hepatitis and after alcohol intake, Ad-TRAIL mediated steatosis can be inhibited by injection of a neutralising TRAIL antibody. Conclusions: We identified TRAIL as a new mediator of hepatic steatosis in viral hepatitis and after alcohol intake. Consequently, TRAIL mediated hepototoxicity has to be considered in patients with viral hepatitis and alcoholic liver disease.


Related Articles

  • Sequence-based discovery of a synthetic peptide inhibitor of caspase 6. Nyormoi, O.; Wang, Z.; Bar-Eli, M. // Apoptosis;Aug2003, Vol. 8 Issue 4, p371 

    We recently demonstrated that tumor necrosis factor alpha activates caspase 6, which in turn cleaves transcription factor AP-2 alpha. We mapped the cleavage site at 19 amino acids from the N-terminus at the sequence aspartate-argenine-histidine-aspartate (DRHD). Mutating aspartic acid at...

  • Selective cytotoxicity of scFv-TNF fusion protein on the tumor cells. Luo, Dong; Li, Hongshi; Tang, Xiao-Bo // Biotechnology Letters;Mar2002, Vol. 24 Issue 6, p441 

    A fusion protein of single-chain, Fv-tumor necrosis factor α, scFv-TNF, was constructed and expressed in the Pichia pastoris expression system. There was 67-fold less toxicity of the fusion protein when compared with TNF-α alone in cells expressing CA125. Furthermore, scFv-TNF was 10-fold...

  • Tumor necrosis factor-α and muscle wasting: a cellular perspective. Reid, Michael B.; Yi-Ping Li // Respiratory Research;2001, Vol. 2, p1 

    Tumor necrosis factor-α (TNF-α) is a polypeptide cytokine that has been associated with muscle wasting and weakness in inflammatory disease. Despite its potential importance in muscle pathology, the direct effects of TNF-α on skeletal muscle have remained undefined until recently....

  • The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Narayan, Nisha; Lee, In Hye; Borenstein, Ronen; Sun, Junhui; Wong, Renee; Tong, Guang; Fergusson, Maria M.; Liu, Jie; Rovira, Ilsa I.; Cheng, Hwei-Ling; Wang, Guanghui; Gucek, Marjan; Lombard, David; Alt, Fredrick W.; Sack, Michael N.; Murphy, Elizabeth; Cao, Liu; Finkel, Toren // Nature;12/13/2012, Vol. 492 Issue 7428, p199 

    Although initially viewed as unregulated, increasing evidence suggests that cellular necrosis often proceeds through a specific molecular program. In particular, death ligands such as tumour necrosis factor (TNF)-? activate necrosis by stimulating the formation of a complex containing...

  • Tumor Necrosis Factor and Lymphotoxin: Molecular Genetics, Regulation and Physiological Role. Nedospasov, S. A. // Russian Journal of Genetics;Feb2003, Vol. 39 Issue 2, p152 

    The data on the regulation of expression and on the biological role of the tumor necrosis factor and lymphotoxin in the author's laboratory, are briefly reviewed in this paper.

  • Permeability of dialyzer membranes to TNFa-inducing substances derived from water bacteria. Lonnemann, Gerhard; Behme, Tim C.; Lenzner, Benedikt; Floege, Juergen; Schulze, Matthias; Colton, Clark K.; Koch, Karl M.; Shaldon, Stanley // Kidney International;Jul1992, Vol. 42 Issue 1, p61 

    Pro-inflammatory cytokine-inducing substances derived from cultured E. coli have previously been shown to pass across low-flux regenerated cellulosic dialyzer membranes. In the present study, a sterile filtrate of Pseudomonas maltophilia grown from standard bicarbonate dialysis fluid was used to...

  • A novel tumor necrosis factor (TNF) gene present in tandem with theTNF-a gene on the same chromosome in teleosts. Savan, Ram; Kono, Tomoya; Igawa, Daisuke; Sakai, Masahiro // Immunogenetics;Apr2005, Vol. 57 Issue 1/2, p140 

    Tumor necrosis factors (TNFs) are pleiotropic cytokines implicated in inflammation, apoptosis, cell proliferation, and a general stimulation of immune system. Although theTNF/lymphotoxin (LT) locus is present in the MHC region of the chromosome in mammals, no such locus has been described from...

  • Silencing TNFa activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Grounds, Miranda D.; Davies, Marilyn; Torrisi, Jo; Shavlakadze, Thea; White, Jason; Hodgetts, Stuart // Cell & Tissue Research;Jun2005, Vol. 320 Issue 3, p509 

    Dramatic clinical success in the treatment of chronic inflammatory diseases has resulted from the use of anti-cytokine therapies including specific blocking antibodies, soluble receptors and traps to silence the actions of inflammatory cytokines such as tumour necrosis factor alpha (TNFa) and...

  • Factor de Necrosis Tumoral-alfa e Interleucina-1 beta en los compartimentos intravascular materno, fetal y retroplacentario en parto a término y pretérmino. Hernandez-Guerrero, Cesar; Vadillo-Ortega, Felipe; Arechavaleta-Velasco, Fabian; Tenorio-Ramos, Javier; Jimenez-Zamudio, Luis; Ahued-Ahued, Jose R.; Beltran-Montoya, Jorge; Neri-Mendez, Carlos // Perinatologia y Reproduccion Humana;jul-sep1999, Vol. 13 Issue 3, p227 

    KEY WORDS: Proinflammatory citokynes, Tumor Necrosis Factor-alpha, Interleukin-1 beta.


Read the Article


Sign out of this library

Other Topics